Back to Browse Categories
Recent articles:
- 10 records -
Research Progress in Predicting Hepatocellular Carcinoma with Portal Vein Tumour Thrombus in the Era of Artificial Intelligence
Li Y, Fan N, He X, Zhu J, Zhang J, Lu L
Journal of Hepatocellular Carcinoma 2024, 11:1429-1438
Published Date: 17 July 2024
Metabolomics in Radiotherapy-Induced Early Adverse Skin Reactions of Breast Cancer Patients
McMahon AN, Lee E, Takita C, Reis IM, Wright JL, Hu JJ
Breast Cancer: Targets and Therapy 2024, 16:369-377
Published Date: 16 July 2024
Silencing Exosomal circ102927 Inhibits Foot Melanoma Metastasis via Regulating Invasiveness, Epithelial-Mesenchymal Transition and Apoptosis
Wan H, Zhong L, Xia T, Zhang D
Cancer Management and Research 2024, 16:825-839
Published Date: 15 July 2024
Research Progress on Ferroptosis and Nanotechnology-Based Treatment in Triple-Negative Breast Cancer
Zhang J, Zhang S, Liu M, Yang Z, Huang R
Breast Cancer: Targets and Therapy 2024, 16:347-358
Published Date: 15 July 2024
Breast Cancer Adjuvant Radiotherapy in Up-Front to Chemotherapy: Is There a Worthwhile Benefit? A Preliminary Report
Lazzari G, Benevento I, Montagna A, D'Andrea B, De Marco G, Castaldo G, Bianculli A, Tucciariello R, Metallo V, Solazzo AP
Breast Cancer: Targets and Therapy 2024, 16:359-367
Published Date: 15 July 2024
Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib and PD-1 Inhibitors for Managing Arterioportal Shunt in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Retrospective Cohort Study
Liu G, Zhu D, He Q, Zhou C, He L, Li Z, Jiang Z, Huang M, Chang B, Wu C
Journal of Hepatocellular Carcinoma 2024, 11:1415-1428
Published Date: 12 July 2024
Multimodal Machine Learning-Based Ductal Carcinoma in situ Prediction from Breast Fibromatosis
Jiang Y, Peng Y, Wu Y, Sun Q, Hua T
Cancer Management and Research 2024, 16:811-823
Published Date: 12 July 2024
UK Stakeholder Perspectives on Surrogate Endpoints in Cancer, and the Potential for UK Real-World Datasets to Validate Their Use in Decision-Making
Baldwin D, Carmichael J, Cook G, Navani N, Peach J, Slater R, Wheatstone P, Wilkins J, Allen-Delingpole N, Kerr CEP, Siddiqui K
Cancer Management and Research 2024, 16:791-810
Published Date: 12 July 2024
Importance of Testing for ROS1 Rearrangements in Non-Small Cell Lung Cancer in the Era of Targeted Therapy in a Latin American Country
Osorio A, Fernandez-Trujillo L, Restrepo JG, Sua LF, Proaño C, Zuñiga-Restrepo V
Cancer Management and Research 2024, 16:781-789
Published Date: 11 July 2024
Efficacy and Safety of Re-Challenging PD-1 Inhibitors in Second-Line Treatment in Metastatic Nasopharyngeal Carcinoma Previously Treated with Chemotherapy and PD-1 Inhibitors
Bei W, Dong S, Liu G, Lin L, Jiang Y, Lu N, Li W, Liang H, Xiang Y, Xia W
Cancer Management and Research 2024, 16:771-780
Published Date: 10 July 2024